Medsafe NZ Safety Alerts

Medsafe Safety Communications: NZ Medicine Monitoring and Alerts

Medsafe, New Zealand's medicines regulator, publishes its updated Safety Communications index listing recent monitoring and alert communications from April 2026 back to January 2025. The communications cover both medicines and medical devices, with recent items including monitoring on Estradot transdermal patches, GLP-1 receptor agonists, atomoxetine, and topiramate, plus an alert on amended driving-impairment legislation. One medical device recall is noted: Euky Bear Warm Steam Vaporiser. The page explains the distinction between monitoring communications (potential safety concerns under investigation) and alert communications (completed reviews with specific advice).

Dear Healthcare Professional Letters - Medicine Safety Alerts

Medsafe NZ publishes a comprehensive index of Dear Healthcare Professional Letters sent by the therapeutic products industry since January 2025, covering 38 distinct safety communications for medicines including Alecensa (alectinib – hypertriglyceridaemia), Columvi (glofitamab – haemophagocytic lymphohistiocytosis), Epilim (valproate – pregnancy risk), Paxlovid (renal impairment), Topiramate Actavis (pregnancy restrictions), and Risperdal (paediatric overdoses). Entries include product name, date sent, linked PDF document, and reason for communication. Letters are published voluntarily on Medsafe's behalf and may not represent a complete record of all safety communications issued.